EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 24 | +9.1% | 0.00% | – |
| Q3 2022 | $0 | – | 22 | -4.3% | 0.00% | – |
| Q2 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 23 | -89.9% | 0.00% | -100.0% |
| Q4 2021 | $6,000 | -70.0% | 227 | -54.2% | 0.00% | -83.3% |
| Q3 2021 | $20,000 | -42.9% | 496 | -19.6% | 0.01% | -50.0% |
| Q2 2021 | $35,000 | +20.7% | 617 | -10.7% | 0.02% | +9.1% |
| Q1 2021 | $29,000 | -31.0% | 691 | +16.5% | 0.02% | -33.3% |
| Q4 2020 | $42,000 | +44.8% | 593 | -42.0% | 0.03% | +37.5% |
| Q3 2020 | $29,000 | +7.4% | 1,022 | +12.1% | 0.02% | +4.3% |
| Q2 2020 | $27,000 | +42.1% | 912 | -3.7% | 0.02% | +15.0% |
| Q1 2020 | $19,000 | -29.6% | 947 | +4.3% | 0.02% | -63.6% |
| Q4 2019 | $27,000 | +28.6% | 908 | -3.7% | 0.06% | +22.2% |
| Q3 2019 | $21,000 | 0.0% | 943 | +11.1% | 0.04% | -11.8% |
| Q2 2019 | $21,000 | +50.0% | 849 | +45.6% | 0.05% | -23.9% |
| Q1 2019 | $14,000 | – | 583 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |